Vendis Capital has hired Rothschild to advise on the sale of Sylphar, a Belgium-based over-the-counter (OTC) health products and cosmetics specialist, two sources familiar with the situation said.
EQT IX is expected to be 70-75% invested following the deal
Previous fund held a final close in 2012 with capital commitments of USD 840m
MoU marks LBO France's first foray into the Chinese market, with plans to open a local office
ECI bought the asset from Phoenix less than three years ago